https://www.sciencedaily.com/news/health_medicine/amyotrophic_lateral_sclerosis/ Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments. en-us Fri, 17 Apr 2026 08:52:42 EDT Fri, 17 Apr 2026 08:52:42 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/amyotrophic_lateral_sclerosis/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260416071951.htm Scientists have discovered that a protein linked to cell death is secretly driving the aging of blood stem cells in a completely different way. Instead of killing the cells, it damages their mitochondria, sapping their energy and weakening the immune system over time. When this protein was turned off, stem cells remained stronger and more balanced, even under stress. The findings point to a new strategy for slowing aging at its source. Thu, 16 Apr 2026 22:58:28 EDT https://www.sciencedaily.com/releases/2026/04/260416071951.htm https://www.sciencedaily.com/releases/2026/04/260415043630.htm A surprising discovery from high-altitude animals like yaks and Tibetan antelopes could reshape how we treat nerve damage in humans. Scientists found that a genetic mutation helping these animals survive low-oxygen environments also protects and repairs the myelin sheath—the vital coating around nerve fibers that’s damaged in diseases like multiple sclerosis (MS) and cerebral paralysis. Wed, 15 Apr 2026 04:36:30 EDT https://www.sciencedaily.com/releases/2026/04/260415043630.htm https://www.sciencedaily.com/releases/2026/04/260413043133.htm Mitochondria don’t just generate energy—they also carefully organize their own DNA in a surprisingly elegant way. Scientists have discovered that a long-overlooked phenomenon called “mitochondrial pearling,” where mitochondria briefly form bead-like shapes, helps evenly space clusters of mitochondrial DNA. Mon, 13 Apr 2026 23:54:52 EDT https://www.sciencedaily.com/releases/2026/04/260413043133.htm https://www.sciencedaily.com/releases/2026/04/260411043048.htm Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing. Sat, 11 Apr 2026 08:13:19 EDT https://www.sciencedaily.com/releases/2026/04/260411043048.htm https://www.sciencedaily.com/releases/2026/04/260408225944.htm A new study reveals that gut bacteria may play a key role in triggering ALS and frontotemporal dementia. Harmful sugars produced by these microbes can spark immune responses that damage the brain. This breakthrough explains why some genetically at-risk people develop the diseases while others don’t. Even more promising, reducing these sugars improved brain health in experiments, hinting at new treatment possibilities. Thu, 09 Apr 2026 06:36:40 EDT https://www.sciencedaily.com/releases/2026/04/260408225944.htm https://www.sciencedaily.com/releases/2026/04/260406192811.htm Your brain’s “stop eating” signal may come from an unexpected source. Researchers found that astrocytes—once thought to just support neurons—actually play a key role in controlling appetite. After a meal, glucose triggers tanycytes, which send signals to astrocytes that then activate fullness neurons. This newly discovered pathway could lead to innovative treatments for obesity and eating disorders. Mon, 06 Apr 2026 19:28:11 EDT https://www.sciencedaily.com/releases/2026/04/260406192811.htm https://www.sciencedaily.com/releases/2026/04/260404082652.htm Many people think that occasional binge drinking is harmless if they otherwise drink in moderation, but new research suggests that assumption may be dangerously wrong. A large U.S. study found that people with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting about one in three adults, face a much higher risk of serious liver scarring if they engage in heavy drinking even just once a month. Sat, 04 Apr 2026 08:29:44 EDT https://www.sciencedaily.com/releases/2026/04/260404082652.htm https://www.sciencedaily.com/releases/2026/04/260402042740.htm A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of reality. The mutation disrupts a brain circuit involved in flexible decision-making, causing mice to stick with outdated choices even when conditions change. Researchers pinpointed the issue to a key thalamus–prefrontal cortex pathway. By reactivating this circuit, they were able to restore normal behavior—raising hope for future therapies. Fri, 03 Apr 2026 03:10:50 EDT https://www.sciencedaily.com/releases/2026/04/260402042740.htm https://www.sciencedaily.com/releases/2026/03/260323005526.htm Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup. Mon, 23 Mar 2026 05:34:10 EDT https://www.sciencedaily.com/releases/2026/03/260323005526.htm https://www.sciencedaily.com/releases/2026/03/260322020302.htm Scientists have uncovered a surprising brain-based trigger for high blood pressure, tracing it to a small region in the brainstem that normally controls breathing. This area, which kicks in during forceful exhalations like coughing, laughing, or exercise, also appears to activate nerves that tighten blood vessels—raising blood pressure. When researchers switched off this region in experiments, blood pressure dropped back to normal, suggesting it plays a direct role in hypertension. Sun, 22 Mar 2026 23:30:22 EDT https://www.sciencedaily.com/releases/2026/03/260322020302.htm https://www.sciencedaily.com/releases/2026/03/260317064457.htm A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed. Tue, 17 Mar 2026 07:44:52 EDT https://www.sciencedaily.com/releases/2026/03/260317064457.htm https://www.sciencedaily.com/releases/2026/03/260314030507.htm A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that TDP43 controls a key DNA repair process, but when the protein becomes imbalanced, the repair system can spiral out of control, harming neurons and destabilizing DNA. The team also discovered that high levels of the protein are linked to increased mutation rates in cancer. The discovery places TDP43 at the center of both neurodegeneration and cancer biology. Sun, 15 Mar 2026 00:05:53 EDT https://www.sciencedaily.com/releases/2026/03/260314030507.htm https://www.sciencedaily.com/releases/2026/03/260311004833.htm Coenzyme A, a molecule derived from vitamin B5, is vital for metabolism throughout the body. Scientists discovered that most of it resides inside mitochondria, yet how it reached these cellular powerhouses was unclear. Yale researchers have now identified the transport system that moves CoA into mitochondria, solving a long-standing biological puzzle. The discovery could help researchers better understand diseases linked to metabolic dysfunction and mitochondrial problems. Wed, 11 Mar 2026 18:32:18 EDT https://www.sciencedaily.com/releases/2026/03/260311004833.htm https://www.sciencedaily.com/releases/2026/03/260311004824.htm A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers found that even a very small dose of EVG7 was highly effective at clearing the infection and preventing it from coming back. Unlike many current antibiotics, which wipe out large portions of the gut microbiome, EVG7 appears to spare beneficial bacteria that naturally help keep C. difficile in check. Wed, 11 Mar 2026 20:19:45 EDT https://www.sciencedaily.com/releases/2026/03/260311004824.htm https://www.sciencedaily.com/releases/2026/03/260311004816.htm A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% fewer pauses in breathing and improved oxygen levels during sleep. The drug helps stabilize breathing signals in the brain, reducing airway collapse. Scientists say the findings could pave the way for a pill-based alternative to CPAP machines. Wed, 11 Mar 2026 06:19:22 EDT https://www.sciencedaily.com/releases/2026/03/260311004816.htm https://www.sciencedaily.com/releases/2026/03/260311004720.htm Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy. Wed, 11 Mar 2026 17:01:42 EDT https://www.sciencedaily.com/releases/2026/03/260311004720.htm https://www.sciencedaily.com/releases/2026/03/260303145705.htm A sweeping new study reveals that what’s on your plate may directly shape the pesticides circulating in your body. Researchers found that people who eat more fruits and vegetables known to carry higher pesticide residues—such as strawberries, spinach, and bell peppers—also have significantly higher levels of those chemicals in their urine. While produce remains a cornerstone of a healthy diet, the findings highlight how everyday food choices can drive real-world exposure to substances linked to cancer, hormone disruption, and developmental harm. Wed, 04 Mar 2026 13:09:52 EST https://www.sciencedaily.com/releases/2026/03/260303145705.htm https://www.sciencedaily.com/releases/2026/02/260225081150.htm Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as “Brain on Fire.” The disease strikes when the immune system attacks NMDA receptors—key molecules involved in memory and thinking—leading to psychiatric symptoms, seizures, and even death. Wed, 25 Feb 2026 11:08:42 EST https://www.sciencedaily.com/releases/2026/02/260225081150.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260217005717.htm Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR-based tool that doesn’t just fight resistant bacteria—it can actively strip away their drug resistance. Inspired by gene drives used in insects, the technology spreads a genetic “fix” through bacterial populations, even inside stubborn biofilms that shield microbes from antibiotics. Wed, 18 Feb 2026 03:08:21 EST https://www.sciencedaily.com/releases/2026/02/260217005717.htm https://www.sciencedaily.com/releases/2026/02/260216044003.htm Researchers have built a realistic human mini spinal cord in the lab and used it to simulate traumatic injury. The model reproduced key damage seen in real spinal cord injuries, including inflammation and scar formation. After treatment with fast moving “dancing molecules,” nerve fibers began growing again and scar tissue shrank. The results suggest the therapy could eventually help repair spinal cord damage. Mon, 16 Feb 2026 07:41:25 EST https://www.sciencedaily.com/releases/2026/02/260216044003.htm https://www.sciencedaily.com/releases/2026/02/260215225606.htm For years, compulsive behaviors have been viewed as bad habits stuck on autopilot. But new research in rats found the opposite: inflammation in a key decision-making brain region actually made behavior more deliberate, not more automatic. The change was linked to astrocytes, brain support cells that multiplied and disrupted nearby circuits. The discovery hints that some compulsive behaviors may arise from excessive, misdirected control rather than a loss of it. Mon, 16 Feb 2026 07:32:28 EST https://www.sciencedaily.com/releases/2026/02/260215225606.htm https://www.sciencedaily.com/releases/2026/02/260212234218.htm Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that special support cells called astrocytes—located far from the actual injury—spring into action after damage. These “lesion-remote astrocytes” send out a protein signal, CCN1, that reprograms immune cells to efficiently clean up fatty nerve debris. Fri, 13 Feb 2026 08:47:43 EST https://www.sciencedaily.com/releases/2026/02/260212234218.htm https://www.sciencedaily.com/releases/2026/01/260129080424.htm Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in the blood tied to how cells handle stress and repair DNA, the team identified a brief early window when Parkinson’s quietly leaves a measurable fingerprint. Thu, 29 Jan 2026 09:26:14 EST https://www.sciencedaily.com/releases/2026/01/260129080424.htm https://www.sciencedaily.com/releases/2026/01/260124003851.htm Chronic inflammation may be quietly reshaping the colon and making it more vulnerable to early-onset colorectal cancer. Scientists found that colon tissue in younger patients was stiffer, even in areas that appeared healthy, suggesting these changes may happen before cancer develops. Lab experiments showed that cancer cells grow faster in rigid environments. Sat, 24 Jan 2026 10:48:02 EST https://www.sciencedaily.com/releases/2026/01/260124003851.htm https://www.sciencedaily.com/releases/2026/01/260122074033.htm New research suggests that auditory hallucinations in schizophrenia may come from a brain glitch that confuses inner thoughts for external voices. Normally, the brain predicts the sound of its own inner speech and tones down its response. But in people hearing voices, brain activity ramps up instead, as if the voice belongs to someone else. The discovery could help scientists develop early warning signs for psychosis. Fri, 23 Jan 2026 08:46:23 EST https://www.sciencedaily.com/releases/2026/01/260122074033.htm https://www.sciencedaily.com/releases/2026/01/260116035348.htm Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN was disabled, tau vanished from neurons and brain cells remained healthy. The findings challenge long-held assumptions about tau’s necessity and highlight a promising new path for fighting Alzheimer’s and brain aging. Scientists now believe OTULIN may act as a master switch for inflammation and age-related brain decline. Fri, 16 Jan 2026 03:53:48 EST https://www.sciencedaily.com/releases/2026/01/260116035348.htm https://www.sciencedaily.com/releases/2026/01/260106001913.htm Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of vital movement-controlling neurons. As their mitochondria fail, these cells weaken and eventually die, worsening motor problems over time. Protecting brain energy systems could open the door to slowing these symptoms. Tue, 06 Jan 2026 03:18:40 EST https://www.sciencedaily.com/releases/2026/01/260106001913.htm https://www.sciencedaily.com/releases/2026/01/260104202813.htm A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, settling a long-running scientific debate. This gentler form of gene editing could offer a safer way to treat Sickle Cell disease by reactivating a fetal blood gene. Researchers say it opens the door to powerful therapies with fewer unintended side effects. Mon, 05 Jan 2026 05:08:21 EST https://www.sciencedaily.com/releases/2026/01/260104202813.htm https://www.sciencedaily.com/releases/2026/01/260104202750.htm Researchers have developed experimental compounds that make cells burn more calories by subtly tweaking how mitochondria produce energy. Older versions of these chemicals were once used for weight loss—but were banned for being deadly. The new approach fine-tunes the effect, allowing cells to burn extra fuel safely. If successful, this could pave the way for new obesity treatments with added health benefits. Mon, 05 Jan 2026 03:56:53 EST https://www.sciencedaily.com/releases/2026/01/260104202750.htm https://www.sciencedaily.com/releases/2025/12/251228074500.htm Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced depression symptoms. However, only Yueju Pill increased a brain-supporting protein associated with mood improvement. Brain imaging showed that unique network patterns—especially in visual regions—could predict who benefited most from Yueju Pill. This opens the door to more personalized depression treatments guided by brain scans. Sun, 04 Jan 2026 20:38:03 EST https://www.sciencedaily.com/releases/2025/12/251228074500.htm https://www.sciencedaily.com/releases/2025/12/251227082720.htm A new gel developed by McGill researchers could change how vocal cord injuries are treated. The injectable material lasts far longer than current options, staying intact for weeks instead of breaking down quickly. By acting like a molecular glue, it gives damaged vocal cords more time to heal. The team hopes it could eventually lead to a gentler, longer-lasting treatment for voice loss. Fri, 02 Jan 2026 12:02:48 EST https://www.sciencedaily.com/releases/2025/12/251227082720.htm https://www.sciencedaily.com/releases/2025/12/251227004155.htm Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone emergency fix that helps them survive. Some cancer cells rely heavily on this backup system, even though it makes their DNA more unstable. Blocking this process could expose a powerful new way to target tumors. Sat, 27 Dec 2025 06:20:32 EST https://www.sciencedaily.com/releases/2025/12/251227004155.htm https://www.sciencedaily.com/releases/2025/12/251222080119.htm New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early damage in mice and reduces inflammation linked to disease progression. The treatment was given before symptoms appeared, targeting the disease at its earliest stage. Researchers say this approach could reshape how Alzheimer’s is prevented and treated. Mon, 22 Dec 2025 08:11:02 EST https://www.sciencedaily.com/releases/2025/12/251222080119.htm https://www.sciencedaily.com/releases/2025/12/251219093315.htm Researchers have revealed that so-called “junk DNA” contains powerful switches that help control brain cells linked to Alzheimer’s disease. By experimentally testing nearly 1,000 DNA switches in human astrocytes, scientists identified around 150 that truly influence gene activity—many tied to known Alzheimer’s risk genes. The findings help explain why many disease-linked genetic changes sit outside genes themselves. The resulting dataset is now being used to train AI systems to predict gene control more accurately. Fri, 19 Dec 2025 11:03:19 EST https://www.sciencedaily.com/releases/2025/12/251219093315.htm https://www.sciencedaily.com/releases/2025/12/251218060557.htm A small tweak to mitochondrial energy production led to big gains in health and longevity. Mice engineered to boost a protein that helps mitochondria work more efficiently lived longer and showed better metabolism, stronger muscles, and healthier fat tissue. Their cells produced more energy while dialing down oxidative stress and inflammation tied to aging. The results hint that improving cellular power output could help slow the aging process itself. Fri, 19 Dec 2025 08:38:24 EST https://www.sciencedaily.com/releases/2025/12/251218060557.htm https://www.sciencedaily.com/releases/2025/12/251217082505.htm A missing brain molecule may be disrupting neural wiring in Down syndrome, according to new research. Replacing it in adult mice rewired brain circuits and improved brain flexibility, challenging the idea that treatment must happen before birth. Wed, 17 Dec 2025 08:25:05 EST https://www.sciencedaily.com/releases/2025/12/251217082505.htm https://www.sciencedaily.com/releases/2025/12/251209234139.htm BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports advanced AI models for decoding movement, perception, and intent. Initial clinical work shows it can be inserted through a small opening in the skull and remain stable while capturing detailed neural activity. The technology could reshape treatments for epilepsy, paralysis, and blindness. Tue, 09 Dec 2025 23:54:39 EST https://www.sciencedaily.com/releases/2025/12/251209234139.htm https://www.sciencedaily.com/releases/2025/12/251208052804.htm Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes this protection, allowing harmful molecules to damage cell membranes and trigger early dementia. Mouse and cell studies showed changes resembling Alzheimer’s. Early tests to slow this damage give scientists new directions to explore. Tue, 09 Dec 2025 04:12:54 EST https://www.sciencedaily.com/releases/2025/12/251208052804.htm https://www.sciencedaily.com/releases/2025/12/251202052230.htm Scientists have discovered that a single gene, GRIN2A, can directly cause mental illness—something previously thought to stem only from many genes acting together. People with certain variants of this gene often develop psychiatric symptoms much earlier than expected, sometimes in childhood instead of adulthood. Even more surprising, some individuals show only mental health symptoms, without the seizures or learning problems usually linked to GRIN2A. Tue, 02 Dec 2025 11:01:34 EST https://www.sciencedaily.com/releases/2025/12/251202052230.htm https://www.sciencedaily.com/releases/2025/11/251126095034.htm Researchers identified a new, sticky form of mitochondrial DNA damage that builds up at dramatically higher levels than in nuclear DNA. These lesions disrupt energy production and activate stress-response pathways. Simulations show the damage makes mtDNA more rigid, possibly marking it for removal. The finding offers fresh clues to inflammation, aging, and diseases such as diabetes and neurodegeneration. Fri, 28 Nov 2025 04:29:25 EST https://www.sciencedaily.com/releases/2025/11/251126095034.htm https://www.sciencedaily.com/releases/2025/11/251126095023.htm Spermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimer’s and Parkinson’s. It encourages these misfolded proteins to gather into manageable clumps that cells can more efficiently dispose of through autophagy. Experiments in nematodes show that spermine also enhances longevity and cellular energy production. These insights open the door to targeted therapies powered by polyamines and advanced AI-driven molecular design. Thu, 27 Nov 2025 07:35:52 EST https://www.sciencedaily.com/releases/2025/11/251126095023.htm https://www.sciencedaily.com/releases/2025/11/251126095020.htm Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus “power packs” to weakened cells, reviving their energy production and resilience. The method bypasses many limitations of current mitochondrial therapies and could offer long-lasting effects. It may open the door to treatments for aging tissues and multiple degenerative diseases. Thu, 27 Nov 2025 06:40:46 EST https://www.sciencedaily.com/releases/2025/11/251126095020.htm https://www.sciencedaily.com/releases/2025/11/251123115703.htm Scientists have uncovered how leukemia cells manage to escape one of the most commonly used treatments. Over time, these cancer cells subtly change the shape of their mitochondria to avoid dying when the drug tries to kill them. By identifying the protein that controls this shape-shifting, researchers were able to block it in mice, making the treatment powerful again and dramatically extending survival. Sun, 23 Nov 2025 11:57:03 EST https://www.sciencedaily.com/releases/2025/11/251123115703.htm https://www.sciencedaily.com/releases/2025/11/251123085550.htm Researchers discovered that raising the protein Sox9 can help the brain’s astrocytes clear out toxic plaque buildup linked to Alzheimer’s. In mouse models that already showed memory problems, activating these cells improved cognitive performance. The treatment also reduced plaque levels over time. The work points toward a natural, cell-based way to slow Alzheimer’s decline. Sun, 23 Nov 2025 09:23:57 EST https://www.sciencedaily.com/releases/2025/11/251123085550.htm https://www.sciencedaily.com/releases/2025/11/251122044335.htm Scientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain inflammation in Alzheimer’s. A small group of these cells seems to have an outsized ability to keep the brain healthier. When a key signal is removed from them, Alzheimer’s symptoms worsen. This pathway may help explain why some people naturally have reduced Alzheimer’s risk. Sat, 22 Nov 2025 13:02:52 EST https://www.sciencedaily.com/releases/2025/11/251122044335.htm https://www.sciencedaily.com/releases/2025/11/251121090726.htm A new airflow device from UBC Okanagan engineers traps exhaled aerosols almost immediately, sharply reducing pathogen exposure in indoor spaces. Early simulations suggest it could outperform existing ventilation systems by a wide margin. Fri, 21 Nov 2025 10:08:14 EST https://www.sciencedaily.com/releases/2025/11/251121090726.htm https://www.sciencedaily.com/releases/2025/11/251117095639.htm Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links between long-lasting pain, depression, inflammation, and rising hypertension risk. Mon, 17 Nov 2025 22:42:19 EST https://www.sciencedaily.com/releases/2025/11/251117095639.htm https://www.sciencedaily.com/releases/2025/11/251114094525.htm Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that power kidney cells. By altering ceramide metabolism or using a new drug candidate, the team was able to protect mitochondrial function and completely prevent kidney injury in mice. Fri, 14 Nov 2025 21:40:47 EST https://www.sciencedaily.com/releases/2025/11/251114094525.htm https://www.sciencedaily.com/releases/2025/11/251113071604.htm Researchers have uncovered surprising evidence that anxiety may be controlled not by neurons but by two dueling groups of immune cells inside the brain. These microglia act like biological pedals—one pushing anxiety forward and the other holding it back. Thu, 13 Nov 2025 08:18:41 EST https://www.sciencedaily.com/releases/2025/11/251113071604.htm https://www.sciencedaily.com/releases/2025/11/251111010000.htm TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional short-term treatments. The therapy may replace bladder removal surgery for many and has earned FDA Priority Review due to its impressive results. Tue, 11 Nov 2025 01:00:00 EST https://www.sciencedaily.com/releases/2025/11/251111010000.htm https://www.sciencedaily.com/releases/2025/11/251110021041.htm Scientists have discovered that most chronic fatigue patients experience dysfunctional breathing, which may worsen their symptoms. The likely culprit is dysautonomia, a disruption in how the body controls blood vessels and muscles. Breathing retraining, yoga, or biofeedback could help restore proper breathing rhythm and ease fatigue. The findings open a promising new path for managing this long-misunderstood illness. Mon, 10 Nov 2025 05:47:39 EST https://www.sciencedaily.com/releases/2025/11/251110021041.htm https://www.sciencedaily.com/releases/2025/11/251108083902.htm Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect memory and brain health, offering a promising new direction for therapy. Sat, 08 Nov 2025 10:40:34 EST https://www.sciencedaily.com/releases/2025/11/251108083902.htm https://www.sciencedaily.com/releases/2025/11/251106003917.htm A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of energy, leading to severe movement problems. The discovery not only deepens understanding of nerve cell metabolism but also points toward potential therapies. Thu, 06 Nov 2025 10:57:46 EST https://www.sciencedaily.com/releases/2025/11/251106003917.htm https://www.sciencedaily.com/releases/2025/11/251106003155.htm Weill Cornell researchers uncovered how free radicals from astrocyte mitochondria can fuel dementia. Using new compounds that target these radicals at their source, they slowed brain inflammation and neuronal damage in mice. The findings reveal a potential breakthrough for treating diseases like Alzheimer’s and frontotemporal dementia by focusing on the precise mechanisms driving degeneration. Thu, 06 Nov 2025 00:31:55 EST https://www.sciencedaily.com/releases/2025/11/251106003155.htm https://www.sciencedaily.com/releases/2025/11/251104094136.htm Researchers have, for the first time, estimated how quickly E. coli bacteria can spread between people — and one strain moves as fast as swine flu. Using genomic data from the UK and Norway, scientists modeled bacterial transmission rates and discovered key differences between strains. Their work offers a new way to monitor and control antibiotic-resistant bacteria in both communities and hospitals. Tue, 04 Nov 2025 23:25:35 EST https://www.sciencedaily.com/releases/2025/11/251104094136.htm https://www.sciencedaily.com/releases/2025/11/251102205021.htm A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve faced doubt and misdiagnosis, it’s a breakthrough that finally validates their experience — and may help diagnose long Covid too. Mon, 03 Nov 2025 02:22:12 EST https://www.sciencedaily.com/releases/2025/11/251102205021.htm https://www.sciencedaily.com/releases/2025/11/251102205014.htm Scientists uncovered how the amino acid leucine enhances mitochondrial efficiency by preserving crucial proteins that drive energy production. By downregulating the protein SEL1L, leucine prevents unnecessary degradation and strengthens the cell’s power output. The findings link diet directly to mitochondrial health and suggest potential therapeutic applications for energy-related diseases. Mon, 03 Nov 2025 09:26:03 EST https://www.sciencedaily.com/releases/2025/11/251102205014.htm https://www.sciencedaily.com/releases/2025/11/251102205012.htm Disrupted sleep patterns in Alzheimer’s disease may be more than a symptom—they could be a driving force. Researchers at Washington University found that the brain’s circadian rhythms are thrown off in key cell types, changing when hundreds of genes turn on and off. This disruption, triggered by amyloid buildup, scrambles normal gene timing in microglia and astrocytes—cells vital for brain maintenance and immune defense. Mon, 03 Nov 2025 01:25:26 EST https://www.sciencedaily.com/releases/2025/11/251102205012.htm https://www.sciencedaily.com/releases/2025/10/251029002855.htm A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It shows no signs of resistance so far, offering hope in the fight against drug-resistant infections and paving the way for new approaches to antibiotic discovery. Wed, 29 Oct 2025 08:42:16 EDT https://www.sciencedaily.com/releases/2025/10/251029002855.htm